通过CMTM4调节瘤炎症信号和药物敏感性
Yitian Xu1,2, Kyeongah Kang1,2, Brian A Coakley3,4
1Immunotherapy Research Center, Houston Methodist Research Institute, Houston, TX, 77030, USA.
The EMBO journal
|February 13, 2025
概括
通过调节EGF信号传递,CMTM4蛋白促进瘤生长和炎症. 抑制CMTM4可以通过减少瘤炎症和增强药物敏感性来改善癌症免疫疗法和化疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 炎症与癌症发展有关,但其在免疫疗法和化疗结果中的作用尚不清楚.
- 在各种癌症中,CMTM4 (CKLF类的MARVEL跨膜域含有成员4) 的表达很高.
研究的目的:
- 研究CMTM4在瘤生长,炎症和对癌症治疗的反应中的作用.
- 探索CMTM4作为增强免疫疗法和化疗的潜在治疗点.
主要方法:
- 在人类和小鼠癌症模型中研究了CMTM4表达 (路易斯肺癌,三阴性乳腺癌,黑色素瘤).
- 使用CMTM4淘汰模式来评估瘤生长,通路激活 (NF-κB,mTOR,PI3K/Akt) 和EGF信号传递.
- 研究了CMTM4在EGFR回收和降解中的作用.
- 在体内使用 CMTM4 向 siRNA 装载脂质体.
- 评估了CMTM4淘汰对免疫检查点封锁和化疗疗效能的影响.
主要成果:
- CMTM4淘汰会减少瘤的生长,并损害关键的促进癌症的途径.
- CMTM4调节了EGF受体 (EGFR) 的循环,使细胞对EGFR抑制剂敏感.
- CMTM4淘汰赛降低了炎症性细胞因子的产生和髓质衍生抑制细胞的招募,创造了一个不那么抑制瘤的微环境.
- 向CMTM4的siRNA脂质体减少了瘤生长和延长了生存时间.
- CMTM4淘汰赛增强了免疫检查点封锁和化疗的疗效.
结论:
- CMTM4是抑制瘤炎症和改善抗癌免疫反应的新目标.
- 向CMTM4可以提高瘤对化疗和免疫治疗的敏感性.
- 降低CMTM4水平提供了一种改善癌症治疗结果的潜在策略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


